BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37016899)

  • 1. A five-gene signature may associate with central nervous system dissemination in adult acute lymphoblastic leukemia.
    Sapienza MR; Chiaretti S; Cardinali D; Mazzara S; Chiarle R; Foà R; Pileri SA
    Hematol Oncol; 2023 Oct; 41(4):789-791. PubMed ID: 37016899
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of ZAP70 kinase in acute lymphoblastic leukemia infiltration into the central nervous system.
    Alsadeq A; Fedders H; Vokuhl C; Belau NM; Zimmermann M; Wirbelauer T; Spielberg S; Vossen-Gajcy M; Cario G; Schrappe M; Schewe DM
    Haematologica; 2017 Feb; 102(2):346-355. PubMed ID: 27686375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous disease in pediatric patients during acute lymphoblastic leukemia (ALL): a review.
    Jin MW; Xu SM; An Q
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6015-6019. PubMed ID: 30280785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origin of a central nervous system lymphoid neoplasm in an immunocompromised host with acute lymphoblastic leukemia.
    Mayer SP; Jayabose S; Tugal O; Ozkaynak MF; Rosenblum-Vos L; Sandoval C
    Leuk Lymphoma; 2002 Sep; 43(9):1881-4. PubMed ID: 12685849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system involvement in childhood acute lymphoblastic leukemia is linked to upregulation of cholesterol biosynthetic pathways.
    Cousins A; Olivares O; Markert E; Manoharan A; Bubnova X; Bresolin S; Degn M; Li Z; Silvestri D; McGregor G; Tumanov S; Sumpton D; Kamphorst JJ; Michie AM; Herzyk P; Valsecchi MG; Yeoh AE; Schmiegelow K; Te Kronnie G; Gottlieb E; Halsey C
    Leukemia; 2022 Dec; 36(12):2903-2907. PubMed ID: 36289348
    [No Abstract]   [Full Text] [Related]  

  • 6. Does minimal central nervous system involvement in childhood acute lymphoblastic leukemia increase the risk for central nervous system toxicity?
    Anastasopoulou S; Harila-Saari A; Als-Nielsen B; Eriksson MA; Heyman M; Johannsdottir IM; Marquart HV; Niinimäki R; Pronk CJ; Schmiegelow K; Vaitkeviciene G; Thastrup M; Ranta S
    Pediatr Blood Cancer; 2022 Jul; 69(7):e29745. PubMed ID: 35488712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal stability of initial leukemia in a child with central nervous system relapse 7.4 years after bone marrow relapse of common acute lymphoblastic leukemic.
    Eckert C; Einsiedel HG; Hartmann R; von Stackelberg A; Völpel S; Guggemos A; Hanzsch N; Kawan L; Seeger K; Henze G
    Haematologica; 2004 Jul; 89(7):ECR23. PubMed ID: 15257960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optimal central nervous system directed therapy in childhood acute lymphoblastic leukemia.].
    Li VC; Li CK
    Zhonghua Er Ke Za Zhi; 2007 May; 45(5):339-43. PubMed ID: 17697618
    [No Abstract]   [Full Text] [Related]  

  • 9. RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia.
    Holland M; Castro FV; Alexander S; Smith D; Liu J; Walker M; Bitton D; Mulryan K; Ashton G; Blaylock M; Bagley S; Connolly Y; Bridgeman J; Miller C; Krishnan S; Dempsey C; Masurekar A; Stern P; Whetton A; Saha V
    Blood; 2011 Jul; 118(3):638-49. PubMed ID: 21606482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JSH practical guidelines for hematological malignancies, 2018: I. leukemia-3. acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL).
    Hatta Y; Hayakawa F; Yamazaki E
    Int J Hematol; 2020 Oct; 112(4):439-458. PubMed ID: 32812190
    [No Abstract]   [Full Text] [Related]  

  • 11. High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.
    Cario G; Izraeli S; Teichert A; Rhein P; Skokowa J; Möricke A; Zimmermann M; Schrauder A; Karawajew L; Ludwig WD; Welte K; Schünemann HJ; Schlegelberger B; Schrappe M; Stanulla M
    J Clin Oncol; 2007 Oct; 25(30):4813-20. PubMed ID: 17947730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management.
    Paul S; Short NJ
    Curr Oncol Rep; 2022 Apr; 24(4):427-436. PubMed ID: 35141858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSTP1 and MDR1 genotypes and central nervous system relapse in childhood acute lymphoblastic leukemia.
    Stanulla M; Schäffeler E; Arens S; Rathmann A; Schrauder A; Welte K; Eichelbaum M; Zanger UM; Schrappe M; Schwab M
    Int J Hematol; 2005 Jan; 81(1):39-44. PubMed ID: 15717687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 12p chromosomal aberrations in precursor B childhood acute lymphoblastic leukemia predict an increased risk of relapse in the central nervous system and are associated with typical blast cell morphology.
    van der Plas DC; Dekker I; Hagemeijer A; Hooijkaas H; Hählen K
    Leukemia; 1994 Dec; 8(12):2041-6. PubMed ID: 7807992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of TCF3 rearrangement on CNS relapse in egyptian pediatric acute lymphoblastic leukemia.
    ElGendi HM; Abdelmaksoud AA; Eissa DG; Abusikkien SA
    Pediatr Hematol Oncol; 2014 Oct; 31(7):638-46. PubMed ID: 25116187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system therapy in acute lymphoblastic leukemia: no more, no less.
    Rives S
    Haematologica; 2023 Dec; 108(12):3193-3194. PubMed ID: 37317901
    [No Abstract]   [Full Text] [Related]  

  • 17. Co-Detection of VEGF-A and Its Regulator, microRNA-181a, May Indicate Central Nervous System Involvement in Pediatric Leukemia.
    Egyed B; Horváth A; Semsei ÁF; Szalai C; Müller J; Erdélyi DJ; Kovács GT
    Pathol Oncol Res; 2022; 28():1610096. PubMed ID: 35449729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system involvement in adult acute lymphoblastic leukemia.
    Thomas X; Le QH
    Hematology; 2008 Oct; 13(5):293-302. PubMed ID: 18854093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ponatinib therapy in recurrent Philadelphia chromosome-positive central nervous system leukemia with T315I mutation after Allo-HSCT.
    He JB; Zhang X; Guo ZW; Liu MM; Xu N; Huang F; Fan ZP; Xuan L; Deng L; Lin SH; Xu J; Sun J; Liu QF
    Int J Cancer; 2020 Aug; 147(4):1071-1077. PubMed ID: 31785158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of central nervous system leukemia in children with acute lymphoblastic leukemia by real-time polymerase chain reaction.
    Pine SR; Yin C; Matloub YH; Sabaawy HE; Sandoval C; Levendoglu-Tugal O; Ozkaynak MF; Jayabose S
    J Mol Diagn; 2005 Feb; 7(1):127-32. PubMed ID: 15681484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.